Ceisteanna ar Pholasaí nó ar Reachtaíocht - Questions on Policy or Legislation
Dail Éireann — 2025-09-18
============================================================

Colm Burke (FG), Cork North-Central

I have a letter in my hand from Dr. Derville O'Shea, consultant haematologist, in respect of a constituent of mine, Aishling Thornhill, who, unfortunately, has relapsed refractory B-cell acute lymphoblastic leukaemia. It is a complicated condition. My understanding is that treatment would be available to her if she was under 25 but because she is over 25 it is not being made available. I understand some progress was made on it this morning. Could the issue be clarified? Where a consultant prescribes that the treatment would be of benefit to a patient over 25, why is a barrier put in place for them? Could the issue be examined in the overall context?

---

Source: Houses of the Oireachtas. Licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). The Official Report is revised after first publication; the fetch timestamp below identifies the version quoted.

Record URI: https://data.oireachtas.ie/akn/ie/debateRecord/dail/2025-09-18/debate/main
Retrieved: 2026-09-14T01:00:58+00:00
Sitting date: 2025-09-18